Standex director Chorman proposes $13.6K share sale
The notice also lists three sales of 50 common shares each during the preceding three months, with their dates and reported values.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Standex International Corp. director Thomas E. Chorman reported a proposed sale of 50 common shares, with an aggregate market value of $13,569.50 and an approximate sale date of October 1, 2026. Fidelity Brokerage Services LLC is listed as broker. The notice lists prior sales of 50 shares each on July 1, August 3, and September 1, 2026, at reported values of $17,775.50, $15,278.00, and $14,244.50. The shares are identified as restricted stock vesting from the issuer on October 26, 2024, as compensation.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.